Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3592]

Researchers determine how a specific protein regulates tumour growth

Researchers determine how a specific protein regulates tumour growth

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

Researchers identify immune-suppressing target in glioblastoma

Researchers identify immune-suppressing target in glioblastoma

High BMI may improve cancer survival

High BMI may improve cancer survival

Researchers identify immune-suppressing target in glioblastoma

Researchers identify immune-suppressing target in glioblastoma

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients

SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for patients with triple-negative breast cancer with lymph node involvement

SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for...

SABCS 2019: Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to yield clinical benefit in patients with operable HER2-positive early breast cancer

SABCS 2019: Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to...

More from ecancer